The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...

and other therapies that are approved by the FDA’s Center for Biologics Evaluation and Research. Among 2024’s notable new drugs were three approvals for antibiotic therapies: Allecra ...

Looking specifically at FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), while not staffed with political appointees, 2025 has ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

Zuckerman is president of the National Center for Health Research and a former congressional investigator on FDA approval standards. Powers is professor of clinical medicine at George Washington ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

As per DelveInsight estimates, North America is anticipated to dominate the global biologics drug substance manufacturing market during the forecast period. In the biologics type segment of the ...

MIRAMAR, Fla. - HCW Biologics Inc. (NASDAQ: HCWB), a clinical-stage biopharmaceutical company with a market capitalization of approximately $12.4 million, announced today that it has received U.S.

announced today the opening of its cutting-edge Center of Excellence for Biologics and Cell and Gene Therapy in the heart of Research Triangle Park (RTP), North Carolina. The new facility expands ...

HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...